Business in the Burbs

Regeneron Q3 loss at $35.8 million

November

Regeneron Pharmaceuticals Inc., a biopharmaceutical company in Eastview that is trying to develop drugs to treat cancer, eye diseases, inflammatory diseases and other conditions, reported this morning it lost $35.8 million, or 54 a share during the third quarter. The loss was wider than the $27.4 million, 48 cents a share, the company had in the third quarter of 2006. Revenues were up to $22.3 million from $15.6 million. The companyÃ¢â‚¬â„¢s shares were down 29 cents, at $19.99, in early trading.

This entry was posted on Tuesday, November 6th, 2007 at 11:00 am by Allan Drury. You can follow any responses to this entry through the RSS 2.0 feed.
Category: Corporate doings

Print | Email

It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the Terms of Service.